Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke Health Care unveils new headquarters at GoCo Health Innovation City, marking a new era of collaboration and innovation
Gothenburg, Sweden, 5 March 2025. Mölnlycke Health Care has now established the new headquarters at GoCo Health Innovation City in the Gothenburg region of Sweden. GoCo is a Life Science knowledge hub that brings together companies, scientists, entrepreneurs, health care providers and talent from around the world. The move underscores Mölnlycke's commitment to embracing partnerships and fostering collaboration to drive the health innovations of tomorrow.
“Placing Mölnlycke together with other key players in Life Science is a game-changer. It opens up entirely new possibilities for us to collaborate with experts from various disciplines, and the chance to practice what we preach: embracing partnerships”, says Zlatko Rihter, CEO of Mölnlycke. “Relocating to this new site is a leap forward for Mölnlycke, preparing us for the future with an office designed to meet the new demands of a workplace.”
Investing in a new headquarters as a founding partner at GoCo Health Innovation City provides a unique opportunity to shape and put Gothenburg’s leading MedTech cluster on the map to help revolutionise care. The move reinforces Mölnlycke's strong commitment to Gothenburg, Sweden, and dedication to continue being an attractive employer in the region and beyond.
The state-of-the-art building features significantly improved collaborative spaces, making it easy for everyone to collaborate and socialise with colleagues, customers, and partners. The new headquarters provides three times more capacity for research and development teams compared to before, making room for innovations that can revolutionise care for people and planet.
-Ends-
For more information, please contact:
Latest news
-
Mölnlycke Health Care strengthens global manufacturing footprint to power future growth in wound care
Gothenburg, Sweden. 8 June 2026. Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech, today confirmed a combined investment of approximately EUR 40 million in Mikkeli, Finland, and Oldham, UK. The investments strengthen the company’s global wound care manufacturing network by increasing capacity, optimising process quality and enhancing supply chain resilience and sustainability.
-
Changes to Mölnlycke Health Care Board of Directors
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
-
5 million and growing: scaling Granudacyn® production in Salzburg
-
Mölnlycke Health Care AB: CEO, Zlatko Rihter, announces resignation, Guillaume Joucla appointed interim CEO
Tue, Mar 24, 2026 Today, it was announced that Zlatko Rihter, CEO of Mölnlycke Health Care, has informed the Board of Directors of his decision to resign. Following his decision, Guillaume Joucla, Chief Financial Officer, has been appointed interim CEO of Mölnlycke Health Care. Mölnlycke’s Board has initiated the recruitment process for a permanent CEO.
-
High burnout among operating room staff poses significant risk to patient safety—new review reveals
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke awarded second consecutive EcoVadis Platinum medal for sustainability performance
Gothenburg, Sweden. 21 August 2025. Mölnlycke®, a world-leading MedTech company, has once again been recognised as a global sustainability leader, earning the prestigious EcoVadis Platinum medal for the second year in a row.
-
EUR bond issue and tender announcement
Mölnlycke intends to issue a new 10-year EUR bond and launches a tender offer for the outstanding EUR 500m bond due February 2025.
-
Mölnlycke Health Care agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturizing.